https://www.selleckchem.com/pr....oducts/NVP-AUY922.ht
that prevented comparative analysis. Registration number PROPSERO; CRD42020210806 . Since the first complete genome sequencing of SARS-CoV-2 in December 2019, more than 550,000 genomes have been submitted into the GISAID database. Sequencing of the SARS-CoV-2 genome might allow identification of variants with increased contagiousness, different clinical patterns and/or different response to vaccines. A highly automated next generation sequencing (NGS)-based method might facilitate an active genomic surveillance of the virus. RNA was
Gefällt mir
Kommentar
Teilen
